Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery New Report

Logo

Naperville, IL -- (ReleaseWire) -- 11/02/2012 --Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery provides key market data on the Asia-Pacific Diabetes Care Devices market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

Scope

- Countries covered include Australia, China, India and Japan.
- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2004 to 2011, forecast forward for 7 years to 2018.
- 2011 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Diabetes Care Devices market..
- Key players covered include F. Hoffmann-La Roche Ltd., LifeScan, Inc., Novo Nordisk A/S, Arkray, Inc., Eli Lilly and Company, Abbott Laboratories and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia-Pacific Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Companies Mentioned

F. Hoffmann-La Roche Ltd. LifeScan, Inc. Novo Nordisk A/S ARKRAY, Inc. Eli Lilly and Company Abbott Laboratories Sanofi Medtronic, Inc. Bayer HealthCare AG Terumo Corporation Becton, Dickinson and Company Nipro Corporation Hindustan Syringes & Medical Devices Ltd. Animas Corporation B. Braun Melsungen AG

To view table of contents for this market report please visit:
http://www.reportstack.com/product/91069/asia-pacific-diabetes-care-devices-market-outlook-to-2018-glucose-monitoring-and-insulin-delivery.html

Media Relations Contact

Web Master
http://www.reportstack.com

View this press release online at: http://rwire.com/176974